Oncogenic mutations in the KRAS gene and the loss of the tumor suppressor functions of the CDNK2A, DPC4/SMAD4, and TP53 genes are frequently observed in PDAC [19], and they are therefore referred to as the most common driver genes in PDAC [20]. This evidence concerns the gene SMAD4 and neoplasm.